News About: Pharm. Industry
With the implementation of Illegal kickback Two-strike out system ahead, inevitable change is expected in the pharmaceutical industry
With the implementation of Illegal kickback Two-strike out system ahead, inevitable wind of change is expected in the center of the pharmaceutical industry.
Some pharmaceutical companies are considering change the us...
There is currently a lot of controversy over the prerequisite of 'Incentive system for reducing pharmaceutical cost'
There is currently a lot of controversy over the prerequisite of 'Incentive system for reducing pharmaceutical cost' in order not to repeat the error of 'Incentive system for low price purchasing'.
First of all, it i...
There appear to be a declining tendency of so called 'Push-in Sales' of pharmaceutical companies
There appear to be a declining tendency of so called 'Push-in Sales' of pharmaceutical companies which was carried out to achieve their results.
The reason is analyzed that as some wholesaler companies went out pf bu...
The concern is gradually increasing that domestic pharmaceutical companies would be degraded into wholesaler companies
The concern is gradually increasing that domestic pharmaceutical companies would be degraded into wholesaler companies.
When looking up increase rate of product sales in 2012, Kwangdong Pharmaceutical recorded the hi...
The amount of health industry increased by 11.0% compared to the date of entry into force of the Korea-US FTA
Korea Health Industry Development Institute has recently announced through the report 'Health industry import and export effectiveness analysis in accordance with tariff elimination, two years after Korea-US FTA takes...
The reason why Shire enters into domestic market is 'Rare and incurable disease'
British pharmaceutical company 'Shire' declared promotion of domestic. There are implications for the appearance of this company. The reason why Shire enters into domestic market is 'Rare and incurable disease'. Shire...
Crestor showed decrease in prescription cost because of keen competition between 47 generics
On June 18, according to the data of Ubist, Crestor recorded prescription cost of 6.3 billion won in May, which is decreased by 13% compared to the prescription cost of 7.2 billion won in April.
The reason why Cresto...
Diabetes treatment succeeded in recording a steady growth curve
According to the recent analysis report of Shinhan Investment Corp., diabetes treatment recorded sales of 45.5 billion won in May which is increased by 6.1% compared to the same period last year, so it succeeded in re...
Some analyzes that solving distribution margin problem of Yuhan Corporation is just a temporary expedient
The problem of distribution margin between wholesaler industry and Yuhan Corporation is getting solved. However, some analyzes that it is just a temporary expedient when viewed as a whole pharmaceutical industry. They...
Multinational pharmaceutical companies analyzed that they would not receive greater benefit from certification business of innovative pharmaceutical company
Recently, 20 pharmaceutical companies submitted application for the second certification business of innovative pharmaceutical company. Among them, the number of multinational pharmaceutical company was only 5 compani...
